VNOV · VitaNova Life Sciences Corp
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Jan 27, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on Jan 27, 2026.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VNOV
this stock
VitaNova Life Sciences Corp
|
$11.51M | — | -68.3% | — | 0.0% |
|
MCK
Mckesson Corp
|
$104.16B | +7.9% | +3.1% | 24.0 | 2.1% |
|
COR
Cencora, Inc.
|
$62.69B | -4.2% | +9.3% | 24.4 | 2.4% |
|
CAH
Cardinal Health Inc
|
$54.57B | +14.2% | +14.2% | — | 2.7% |
|
HSIC
Henry Schein Inc
|
$9.98B | +18.8% | +5.9% | 26.1 | 6.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Jan 27, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VNOV | — | — | — | — | — |
| SPY | +3.3% | +9.3% | +4.7% | +9.0% | +3.9% |
| vs SPY | — | — | — | — | — |